DUXAP10 is the only pseudogene significantly overexpressed across all four GEO datasets and is frequently upregulated in multiple cancers, including liver hepatocellular carcinoma, bladder cancer, and esophageal cancer. Here, DUXAP10 is linked to urinary bladder cancer.